Mark Daniel Fleming, D.Phil., M.D.
Title S. Burt Wolbach Professor of Pathology Institution Boston Children's Hospital Address Childrens Hospital
Pathology, Bader 124.1
300 Longwood Ave
Boston MA 02115
|
|
Title
Head of the Department of Pathology at Boston Children's Hospital
Institution
Boston Children's Hospital
Research
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
Faculty can
login
to make corrections and additions.
-
R01HL153970
(FINLEY, DNAIEL J ;FLEMING, MARK D)
Apr 1, 2021 - Mar 31, 2025
Erythrocyte maturation through global remodeling of the proteome
Role: Co-Principal Investigator
-
RC2DK122533
(FIGUEROA, MARIA EUGENIA;FLEMING, MARK D;LINDSLEY, ROBERT COLEMAN;SHIMAMURA, AKIKO)
Sep 15, 2019 - Jun 30, 2024
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine
Role: Co-Principal Investigator
-
R01HL125710
(FINLEY, DANIEL J)
May 15, 2015 - Jun 30, 2019
A novel program of ubiquitination in global remodeling of the erythroid proteome
Role: Co-Principal Investigator
-
R24DK099808
(SHIMAMURA, AKIKO)
Sep 29, 2013 - Aug 31, 2019
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
Role: Co-Principal Investigator
-
R01DK100806
(FLEMING, MARK D)
Sep 18, 2013 - Jun 30, 2018
Murine Models of Heme Metabolism and Iron Recycling
Role: Principal Investigator
-
R24DK094746
(WILLIAMS, DAVID A)
Aug 1, 2012 - Feb 28, 2014
Molecular Genetic Investigation of Pediatric Myelodysplastic Syndrome
Role: Co-Principal Investigator
-
R21HL116210
(FINLEY, DANIEL J)
May 15, 2012 - Oct 30, 2014
Ubiquitination in erythropoiesis and the pathophysiology of anemia
Role: Co-Principal Investigator
-
T32HL110852
(FLEMING, MARK D)
May 1, 2012 - Apr 30, 2019
Pediatric Pathology Translational Research
Role: Principal Investigator
-
R01DK087992
(FLEMING, MARK D)
May 1, 2011 - Apr 30, 2017
Molecular Genetics of Sideroblastic Anemia
Role: Principal Investigator
-
RC1DK086486
(FLEMING, MARK D)
Sep 21, 2009 - Jul 31, 2012
Hepcidin-based screening for infantile iron deficiency
Role: Principal Investigator
-
RC1DK086861
(WILLIAMS, DAVID A)
Sep 21, 2009 - Jul 31, 2012
Development of a Pediatric Mylelodysplastic Syndrome Patient Registry
Role: Principal Investigator
-
T32HL076115
(FLEMING, MARK D)
Jul 1, 2005 - Jun 30, 2011
Pathobiology of the Developing Cardiovascular System
Role: Principal Investigator
-
R01DK080011
(FLEMING, MARK D)
Jul 1, 2003 - Aug 31, 2012
Metalloreductases in Medicine
Role: Principal Investigator
-
R56DK080011
(FLEMING, MARK D)
Jul 1, 2003 - Aug 31, 2007
Metalloreductases in Medicine
Role: Principal Investigator
-
R01HL074247
(FLEMING, MARK D)
Jul 1, 2003 - Jun 30, 2007
nm1054: a new murine iron deficiency anemia mutant
Role: Principal Investigator
-
R01DK062474
(FLEMING, MARK D)
Apr 1, 2002 - Mar 31, 2007
Sideroflexin 1 and mitochondrial iron metabolism
Role: Principal Investigator
-
K08HL003600
(FLEMING, MARK D)
Feb 1, 1997 - Jan 31, 2002
MURINE IRON METABOLISM MUTATION MICROCYTOSIS (MK)
Role: Principal Investigator
-
R01HL035716
(COLLINS, TUCKER O)
Sep 30, 1985 - Feb 29, 2008
ENDOTHELIAL GENE EXPRESSION CONTROL OF PDGF PRODUCTION
Role: Co-Principal Investigator
Bibliographic
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.